Literature DB >> 7349975

Beta-endorphin-induced decrease in hypothalamic dopamine turnover.

G R van Loon, D Ho, C Kim.   

Abstract

The effect of beta-endorphin on hypothalamic dopamine metabolism was examined in male rats. Intracisternal administration of synthetic human beta-endorphin (15 microgram blunted the alpha-methyltyrosine-induced decline in the concentration of hypothalamic dopamine. Also, beta-endorphin blunted the pargyline-induced accumulation of hypothalamic dopamine. beta-Endorphin either increased or failed to alter the basal concentration of hypothalamic dopamine and failed to alter the basal hypothalamic concentration of the dopamine metabolite, homovanillic acid. These data suggest that beta-endorphin decreases the turnover rate of hypothalamic dopamine and are consistent with the thesis that beta-endorphin decreases the release of dopamine from tuberoinfundibular dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7349975     DOI: 10.1210/endo-106-1-76

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats.

Authors:  Bo Zhang; Yueping Hou; James L Voogt
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

2.  Effects of naloxone infusion on nocturnal prolactin secretion and Fos/FRA expression in pregnant rats.

Authors:  Y Hou; J L Voogt
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

3.  Serum concentrations of PRL, GH, LH, FSH, TSH and cortisol after single administration to man of a new synthetic narcotic analgesic butorphanol.

Authors:  E Rolandi; R Franceschini; A Marabini; V Messina; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man.

Authors:  G Jungkunz; N Nedopil; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  A possible role of endogenous opioids in the control of prolactin and luteinizing-hormone secretion in the human.

Authors:  J D Veldhuis; T J Worgul; R Monsaert; J M Hammond
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

6.  Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes.

Authors:  A E Pontiroli; A De Pasqua; R Colombo; C Ricordi; G Pozza
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

7.  Effects of dopamine on prolactin secretion and cyclic AMP accumulation in the rat anterior pituitary gland.

Authors:  K P Ray; M Wallis
Journal:  Biochem J       Date:  1981-01-15       Impact factor: 3.857

Review 8.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 9.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

10.  Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons.

Authors:  I Ganzetti; F Petraglia; I Capuano; F Rosi; W B Wehrenberg; E E Müller; D Cocchi
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.